The Peptide Report
A quiet cohort of Silicon Valley founders is rebuilding the afternoon focus routine around a doctor-formulated peptide nasal spray. Here's what the science says — and why the productivity stack of 2026 looks nothing like 2019's.
A quiet cohort of operators has retired the afternoon espresso in favor of a peptide-based nasal spray. Here's what the science says — and why it matters in 2026.
The 3 PM crash isn't a personal failing — it's a predictable neurochemical event. Here's how a new category of intranasal wellness tools is helping knowledge workers reclaim the second half of their day.
Inside the quiet shift happening on Silicon Valley's engineering floors, where high performers are trading caffeine crashes for a doctor-formulated peptide nasal spray. A feature on the science, the culture, and the rise of intranasal cognitive support.
The 3 PM productivity crash isn't a willpower problem—it's a delivery problem. Here's why intranasal absorption is quietly replacing the fourth espresso in high-performance circles.
The afternoon productivity crash isn't a discipline problem — it's a mitochondrial one. A new generation of high-performers is reaching for NAD+ instead of a fourth espresso.
